<?xml version="1.0" encoding="UTF-8"?><ConditionDefinition xmlns="http://hl7.org/fhir">
  <id value="example"/>
  <meta>
    <security>
      <system value="http://terminology.hl7.org/CodeSystem/v3-ActReason"/>
      <code value="HTEST"/>
      <display value="test health data"/>
    </security>
  </meta>
  <text><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: ConditionDefinition</b><a name="example"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource ConditionDefinition "example" </p></div><p><b>url</b>: <code>http://hl7.org/fhir/ConditionDefinition/example</code></p><p><b>identifier</b>: id: urn:oid:2.16.840.1.113883.4.642.25.1</p><p><b>name</b>: Hyperlipidemia</p><p><b>title</b>: Hyperlipidemia Status</p><p><b>status</b>: draft</p><p><b>date</b>: 2019-05-26T10:44:00+10:00</p><p><b>description</b>: Hyperlipidemia Status</p><p><b>code</b>: Hyperlipidemia (disorder) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#55822004)</span></p><p><b>hasSeverity</b>: false</p><p><b>hasBodySite</b>: false</p><p><b>hasStage</b>: false</p><p><b>definition</b>: <a href="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf">https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf</a></p><blockquote><p><b>observation</b></p><p><b>code</b>: Lipid Panel <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#24331-1 "Lipid 1996 panel - Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#35200-5 "Cholesterol [Moles/​volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Triglyceride <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#35217-9 "Triglyceride [Moles/​volume] in Serum or Plasma")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: Cholesterol in HDL <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#2085-9 "HDL Cholesterol")</span></p></blockquote><blockquote><p><b>observation</b></p><p><b>code</b>: LDL Chol. (Calc) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://loinc.org/">LOINC</a>#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")</span></p></blockquote><h3>Medications</h3><table class="grid"><tr><td>-</td><td><b>Code</b></td></tr><tr><td>*</td><td>Gemfibrozil <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.1.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#203151)</span></td></tr></table><h3>Plans</h3><table class="grid"><tr><td>-</td><td><b>Reference</b></td></tr><tr><td>*</td><td><a href="broken-link.html">http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6</a></td></tr></table></div></text><url value="http://hl7.org/fhir/ConditionDefinition/example"/>
  <identifier>
    <system value="urn:ietf:rfc:3986"/>
    <value value="urn:oid:2.16.840.1.113883.4.642.25.1"/>
  </identifier>
  <name value="Hyperlipidemia"/>
  <title value="Hyperlipidemia Status"/>
  <status value="draft"/>
  <date value="2019-05-26T10:44:00+10:00"/>
  <description value="Hyperlipidemia Status"/>
  <code>
    <coding>
      <system value="http://snomed.info/sct"/>
      <code value="55822004"/>
      <display value="Hyperlipidemia (disorder)"/>
    </coding>
  </code>
  <hasSeverity value="false"/>
  <hasBodySite value="false"/>
  <hasStage value="false"/>
  <definition value="https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"/>
  <observation>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="24331-1"/>
        <display value="Lipid 1996 panel - Serum or Plasma"/>
      </coding>
      <text value="Lipid Panel"/>
    </code>
  </observation>
  <observation>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="35200-5"/>
        <display value="Cholesterol [Moles/​volume] in Serum or Plasma"/>
      </coding>
      <text value="Cholesterol"/>
    </code>
  </observation>
  <observation>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="35217-9"/>
        <display value="Triglyceride [Moles/​volume] in Serum or Plasma"/>
      </coding>
      <text value="Triglyceride"/>
    </code>
  </observation>
  <observation>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="2085-9"/>
        <display value="HDL Cholesterol"/>
      </coding>
      <text value="Cholesterol in HDL"/>
    </code>
  </observation>
  <observation>
    <code>
      <coding>
        <system value="http://loinc.org"/>
        <code value="13457-7"/>
        <display value="Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation"/>
      </coding>
      <text value="LDL Chol. (Calc)"/>
    </code>
  </observation>
  <medication>
    <code>
      <coding>
        <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
        <code value="203151"/>
        <display value="Gemfibrozil"/>
      </coding>
    </code>
  </medication>
  <plan>
    <reference>
      <reference value="http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"/>
    </reference>
  </plan>
</ConditionDefinition>